
Novo Nordisk has begun work on a new $2 billion production facility in Clayton, North Carolina, which will produce active …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

